EP1230353A4 - Bifunctional molecules and their use in the disruption of protein-protein interactions - Google Patents

Bifunctional molecules and their use in the disruption of protein-protein interactions

Info

Publication number
EP1230353A4
EP1230353A4 EP20000980512 EP00980512A EP1230353A4 EP 1230353 A4 EP1230353 A4 EP 1230353A4 EP 20000980512 EP20000980512 EP 20000980512 EP 00980512 A EP00980512 A EP 00980512A EP 1230353 A4 EP1230353 A4 EP 1230353A4
Authority
EP
European Patent Office
Prior art keywords
protein
disruption
bifunctional molecules
interactions
protein interactions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP20000980512
Other languages
German (de)
French (fr)
Other versions
EP1230353A1 (en
Inventor
Gerald R Crabtree
Kryn Stankunas
Roger Briesewitz
Thomas Wandless
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Original Assignee
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leland Stanford Junior University filed Critical Leland Stanford Junior University
Publication of EP1230353A1 publication Critical patent/EP1230353A1/en
Publication of EP1230353A4 publication Critical patent/EP1230353A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EP20000980512 1999-11-19 2000-11-17 Bifunctional molecules and their use in the disruption of protein-protein interactions Withdrawn EP1230353A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16667599P 1999-11-19 1999-11-19
US166675P 1999-11-19
PCT/US2000/031695 WO2001036612A1 (en) 1999-11-19 2000-11-17 Bifunctional molecules and their use in the disruption of protein-protein interactions

Publications (2)

Publication Number Publication Date
EP1230353A1 EP1230353A1 (en) 2002-08-14
EP1230353A4 true EP1230353A4 (en) 2002-11-06

Family

ID=22604262

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20000980512 Withdrawn EP1230353A4 (en) 1999-11-19 2000-11-17 Bifunctional molecules and their use in the disruption of protein-protein interactions

Country Status (3)

Country Link
EP (1) EP1230353A4 (en)
AU (1) AU1776501A (en)
WO (1) WO2001036612A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7498025B1 (en) 1999-11-19 2009-03-03 The Board Of Trustees Of The Leland Stanford Junior University Targeted bifunctional molecules and therapies based thereon
US9428845B1 (en) 2010-12-28 2016-08-30 Warp Drive Bio, Inc. Identifying new therapeutic agents
WO2016112295A1 (en) 2015-01-09 2016-07-14 Warp Drive Bio, Inc. Compounds that participate in cooperative binding and uses thereof
AU2016329064B2 (en) 2015-10-01 2023-10-19 Warp Drive Bio, Inc. Methods and reagents for analyzing protein-protein interfaces
US10907188B2 (en) 2016-04-12 2021-02-02 Ginkgo Bioworks, Inc. Compositions and methods for the production of compounds
US11479797B2 (en) 2016-10-28 2022-10-25 Ginkgo Bioworks, Inc. Compositions and methods for the production of compounds
WO2021091956A1 (en) 2019-11-04 2021-05-14 Revolution Medicines, Inc. Ras inhibitors
JP2022553857A (en) 2019-11-04 2022-12-26 レボリューション メディシンズ インコーポレイテッド RAS inhibitor
EP4054719A1 (en) 2019-11-04 2022-09-14 Revolution Medicines, Inc. Ras inhibitors
PE20231207A1 (en) 2020-09-15 2023-08-17 Revolution Medicines Inc INDOLIC DERIVATIVES AS RAS INHIBITORS IN CANCER TREATMENT

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999061055A1 (en) * 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1119876A (en) * 1993-02-12 1996-04-03 莱兰斯坦福初级大学评议会 Regulated transcription of targeted genes and other biological events

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999061055A1 (en) * 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0136612A1 *

Also Published As

Publication number Publication date
AU1776501A (en) 2001-05-30
EP1230353A1 (en) 2002-08-14
WO2001036612A1 (en) 2001-05-25

Similar Documents

Publication Publication Date Title
HK1084109A1 (en) 2-,3-,4-,or 5-substituted-n1-(benzensulfonyl) indoles and their use in therapy 2-
AU2001293553A1 (en) Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
IL205242A0 (en) Substituted oxazolidinones and their use in the field of blood coagulation
HK1039637A1 (en) Heteroduplex mutational vectors and use thereof in bacteria
HU9902952D0 (en) Water-soluble pharmaceutical copositions in an ionic complex and the use thereof
HUP0101137A3 (en) Anticoagulant amidines and their pharmaceutical use
PT1212317E (en) INDOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF OSTEOPOROSIS BETWEEN OTHER APPLICATIONS
HUP0203896A3 (en) Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof
HUP0203811A3 (en) Use of polymeric material in the treatment of hard surfaces
EP1230353A4 (en) Bifunctional molecules and their use in the disruption of protein-protein interactions
EP1147213A4 (en) Novel rgs-containing molecules and uses thereof
AU2841801A (en) Triazolotriazinones and the use thereof
GB2352234B (en) Improvements in and relating to portable disc holders
AU2001266229A1 (en) Hcn polypeptides and polynucleotides and their use in therapy
GB2370233B (en) Apparatus for use in behaviour modification and the like
PL347542A1 (en) Therapeutic product and its use
IL127518A0 (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
PL363048A1 (en) Azabicyclic derivatives and their therapeutic use
AU2001277119A1 (en) Human kininogen d5 domain polypeptides and their use
ZA981782B (en) The use of levobupivacaine in combination with other drugs
AU3294700A (en) Self-contained and mobile washstand for recurrent use in medical environment
EP1229924A4 (en) Targeted bifunctional molecules and therapies based thereon
GB9929581D0 (en) Comjpositions and their use
AU2002220626A1 (en) 3-nitroisoxazoles and their use in the protection of materials
HU9900045D0 (en) Improved leukaemic blood-based product and their use in therapy

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020506

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched
AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20021106

17Q First examination report despatched

Effective date: 20060524

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070519